baber/WOPTO huggingface dataset:
Patent NZ-525317-A (NZ)
Title: Automatic pipetting device with rinsing
Inventor: ABOU-SALEH KHALED
IPC: G01N35/00
Filed: 2001-10-11
Abstract: A device comprising two cylinder/piston pumping units (1, 2) whereof the rods are driven in translation by common motoring means (MC). The working chamber of the two pumping units (1, 2) is connected to a circuit comprising successively a conduit emerging into a rinsing liquid reserve (RL), two successive electromagnetic valves (EV1, EV2) and a pipe (TS) connected to a pipetting means (AP), the larger working chamber being connected in the part of the circuit providing the junction between the electromagnetic valves while the other working chamber is connected in the part of the circuit located between the second electromagnetic valve (EV2) and the pipetting means.
Patent NZ-529084-A (NZ)
Title: New imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: RAULT SYLVAIN
IPC: A61K31/402
Filed: 2003-10-22
Abstract: Compounds of formula (I), wherein: R1 represents an optionally substituted heteroaryl group R2 represents an optionally substituted cycloalkyl group R3 represents a hydrogen atom or an alkyl group, and R4 and R5, which may be identical or different, each represents a hydrogen atom, a halogen atom or an alkyl, polyhaloalkyl, R10-C(X)-R11-, R10-Y-C(X)-R11-, R10-C(X)-Y-R11-, R10-Y-R11- or R10-S(O)n-R11 group, in which: R10 represents a hydrogen atom or an alkyl group, R11 represents a bond, or an alkylene, alkenylene or alkynylene group, X represents an oxygen atom, a sulphur atom, or an NR12 group in which R12 represents a hydrogen atom or an alkyl group, Y represents an oxygen atom, a sulphur atom, or an amino or alkylamino group, and n represents an integer of form 1 to 2 inclusive, pharmaceutical compositions comprising compounds of formula (I) and a process for their preparation are disclosed. The compounds disclosed are useful in the treatment of non-insulin-dependent type II diabetes, obesity, type I diabetes, hyperlipidaemia, hypercholesterolaemia and cardiovascular complications thereof.
Patent NZ-530644-A (NZ)
Title: Herbicide combinations comprising special sulphonyl ureas
Inventor: HACKER ERWIN
IPC: A01N37/46
Filed: 2002-07-12
Abstract: Herbicide combinations containing components (A) and (B), which exhibit an improved herbicidal action are disclosed, wherein: (A) is one or more herbicides of formula (I) or the salts thereof, in which R1 represents a (C1-C8) alkyl, (C3-C4) alkenyl, (C3-C4) alkynyl or (C1-C4) alkyl, which is monosubstituted to tetrasubstituted by radicals from the group containing halogen and/or (C1-C2) alkoxy; R2 represents I or CH2NHSO2CH3; R3 represents methyl or methoxy; and Z represents N or CH; and (B) is one or more herbicides, which are selectively effective in several monocotylic cultures against monocotylic and/or dicotylic harmful plants, which herbicides are selected from the group of compounds consisting of (B1) flucarbazone, (B2) BAY MKH 6561 (procarbazone), (B3) florasulam, (B4) halosulfuron, (B5) tritosulfuron, (B6) picolinafen, (B7) cinidon-ethyl, (B8) mesotrione, (B9) metosulam, (B10) clopyralid, (B11) flufenacet, (B12) flumetsulam, (B13) flupoxam, (B14) prosulfocarb, (B15) flurtamone, (B16) aclonifen, (B17) hexazinone, (B18) asulam, (B19) diuron, (B20) ametryn, (B21) isoxaflutole, (B22) amicarbazone, and (B23) trifloxysulfuron, except for herbicide combinations, which contain (A) one or more herbicides from the group of compounds of formula (I) and the salts thereof, in which R1=(C1-C8) alkyl, (C3-C4) alkenyl, (C3-C4) alkynyl or (C1-C4) alkyl, which is monosubstituted to tetrasubstituted by radicals from the group containing halogen and (C1-C2) alkoxy, R2= CH2NHSO2CH3, R3= methoxy and Z = CH, and (B) is one or more herbicides from the group of compounds containing metosulam (B9), flupoxam (B13), prosulfocarb (B14) and flurtamone (B15).
Patent NZ-533255-A (NZ)
Title: Sealed container with enclosed opening means
Inventor: TSAUR GARRY
IPC: B65D75/48
Filed: 2004-05-28
Abstract: Disclosed is a container with enclosed opening means (5) comprising a flexible elongated tubular housing (1) with a sealed end (2) and an open end (3), a liquid (4) enclosed within the flexible elongated tubular housing near the sealed end, the enclosed opening means disposed inside the flexible elongated tubular housing sealing the liquid within the flexible elongated tubular housing wherein the opening means may be operated to release the liquid from the flexible elongated tubular housing.
Patent NZ-534806-A (NZ)
Title: Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin B12
Inventor: COELINGH BENNINK HERMAN JAN TI
IPC: A61K31/566
Filed: 2002-11-15
Abstract: Disclosed is a kit for use in contraception or hormone replacement therapy in mammalian females comprising a plurality of dosage units consisting: At least 1 micro gram of one or more steroids selected from estrogens or progestogens At least 1 micro gram of tetrahydrofolate components. At least 0.1mg of vitamin B12. The disclosed kit is primarily to realise the benefits of folate supplementation in methods of contraception and hormone replacement therapy. However it may also be of use in prevention of folate deficiency generally.
Patent NZ-535315-A (NZ)
Title: Immunosuppressant compounds, methods and uses related thereto
Inventor: NAGY ZOLTAN
IPC: A61P17/02
Filed: 2003-03-24
Abstract: Disclosed is a compound having a structure of Formula II: wherein, as valence and stability permit, A is absent or represents a sequence of from one to four amino acid or amino acid analog residues; B represents a sequence of from two to eight amino acid or amino acid analog residues; W represents OR7 or NR8R9, V, independently for each occurrence, represents C=O, C=S, or S02; X is absent or represents O, S, or NR; R, independently for each occurrence, represents H or lower alkyl; R, represents a substituted or unsubstituted alkyl, heteroalkyl, alkenyl, alkynyl, aryl, aralkyl, heteroaryl, heteroaralkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, or heterocyclylalkyl moiety; R2 represents a substituted or unsubstituted alkyl, heteroalkyl, alkenyl, alkynyl, aryl, aralkyl, heteroaryl, heteroaralkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, or heterocyclylalkyl moiety, or R2 and R, taken together, form a ring having from 5 to 7 members, optionalIy being substituted with from 1 to 5 substituents and/or forming a polycyclic structure with one or more other rings; i represents an integer from 0-1; j represents an integer from 1-2; k represents an integer from 1-3; and R6 is absent or represents from 1-4 substituents on the nitrogen-containing ring to which it is attached, selected from substituted or unsubstituted lower alkyl, haloalkyl, halogen, hydroxyl, and amino; and R7, R, and R9 independently represent substituents selected from H and substituted or unsubstituted alkyl, heteroalkyl, aryl, aralkyl, heteroaralkyl, heteroaryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl, or where R8 and R9, taken together, form a ring having from 5 to 7 members, optionally being substituted with from 1 to 5 substituents and/or forming a polycyclic structure with one or more other rings. Also disclosed is the of the above compounds in the manufacture of a medicament used for treating or preventing a condition characterized by MHC class II-mediated activation of T cells or expression of an MHC class II protein at a pathological site of inflammation.
Patent NZ-535397-A (NZ)
Title: A method and apparatus for purchasing an electronic file
Inventor: MULLER NATHAN JAMES
Filed: 2004-09-17
Abstract: A method for purchasing an electronic file being broadcast by a broadcaster (2) is disclosed. An order signal is sent to an entity (3) associated with the broadcaster confirming a user's (6) intention to purchase the file being broadcast at the time of sending the order signal. The identified file is then sent to the user and stored on electronic storage means.
Patent NZ-542623-A (NZ)
Title: A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1H)-quinolin-2-ones
Inventor: LOHSE OLIVIER
IPC: C07D215/26
Filed: 2004-04-01
Abstract: Disclosed is a process for preparing 5-(alpha-haloacetyl)-8-substituted oxy-(1H)-quinolin-2-ones comprising: (a) reacting (i) 8-hydroxy-(1H)-quinolin-2-one with an acylating agent and a Lewis acid to form 5-acetyl-8-hydroxy-(1H)-quinolin-2-one; or (ii) 8-hydroxy-(1H)-quinolin-2-one with an acylating agent to form 8-acetoxy-(1H)-quinolin-2-one, and treating, in-situ, the 8-acetoxy-(1H)-quinolin-2-one with a Lewis acid to form 5-acetyl-8-hydroxy-(1H)-quinolin-2-one; or (iii) 8-acetoxy-(1H)-quinolin-2-one with a Lewis acid to form 5-acetyl-8-hydroxy-(1H)-quinolin-2-one; (b) reacting the 5-acetyl-8-hydroxy-(1H)-quinolin-2-one prepared in Step (a) with a compound having the Formula RL in the presence of a base and a solvent to form 5-acetyl-8-substituted oxy-(1H)-quinolin-2-one, wherein R is a protecting group and L is a leaving group; and (c) reacting the 5-acetyl-8-substituted oxy-(2H)-quinolin-2-one with a halogenating agent in the presence of a solvent to form a 5-(alpha-haloacetyl)-8-substituted oxy-(1H)-quinolin-2-one.
Patent NZ-544618-A (NZ)
Title: Antibodies specific for sclerostin and methods for increasing bone mineralization
Inventor: WINKLER DAVID G
IPC: C07K16/18
Filed: 2004-06-15
Abstract: Disclosed are compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures.
Patent NZ-551476-A (NZ)
Title: Protein isolation procedures for reducing phytic acid
Inventor: SCHWEIZER MARTIN
IPC: A23L11/30
Filed: 2005-05-06
Abstract: Provided is a process of preparing a canola protein isolate, which includes: (a) extracting a canola oil seed meal with an aqueous solution of calcium chloride having an ionic strength of about 0.05 and a pH of 5 to 6.8 to cause solubilization of protein in said oil seed meal to form an aqueous protein solution while inhibiting the extraction of phytic acid from the oil seed meal into the protein solution, (b) separating the aqueous protein solution from residual oil seed meal, (c) increasing the protein concentration of the aqueous protein solution to a concentration of at least 50 g/L while maintaining the ionic strength substantially constant to provide a concentrated protein solution, (d) diluting said concentrated protein solution into chilled water having a temperature below 15°C to cause formation of protein micelles, (e) settling the protein micelles to form an amorphous, sticky, gelatinous, gluten-like micellar mass, and (f) separating the protein micellar mass from supernatant having a protein content of at least 90 wt% (N x 6.25) on a dry weight basis. Further provided are similar processes with specific physical conditions as well as proteins produced by the said processes.
Patent NZ-556292-A (NZ)
Title: Novel salt form of a dopamine agonist, 5-[(2R,5S)-5-methyl-4-propylmorpholin-2-yl]pyridin-2-amine di-S-camsylate
Inventor: GREEN STUART PETER
IPC: C07C309/07
Filed: 2006-01-26
Abstract: Disclosed is the salt 5-[(2R,5S)-5-methyl-4-propylmorpholin-2-yl]pyridin-2-amine di-S-camsylate, as shown in the figure. Also disclosed is the use of this salt for treating sexual dysfunction such as male erectile dysfunction or female sexual dysfunction. Also disclosed is the use of the salt for treating neuropsychiatric disorders or neurodegenerative disorders. Also disclosed is a process for preparing the monohydrate of the above salt.
Patent NZ-564768-A (NZ)
Title: 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
Inventor: HIMMELSBACH FRANK
Filed: 2003-08-18
Abstract: Disclosed is a combination of a compound of general formula I or a tautomer, an enantiomers, a diastereomer, or a mixture thereof or a salt thereof, and one or more other therapeutic agents wherein: R1 denotes a 4-methoxy-1-naphthylmethyl group, a 2-quinolinylmethyl, a 4-quinolinylmethyl, a 6-quinolinylmethyl group, a 1-isoquinolinylmethyl, 3-methyl-1-isoquinolinylmethyl, a 4-methyl-1-isoquinolinylmethyl, a 3-isoquinolinylmethyl group, a 2-quinazolinylmethyl, a 4-methyl-2-quinazolinylmethyl or a 4-quinazolinylmethyl group, and R3 denotes a 2-buten-1-yl or a 2-butyn-1-yl group.
Patent NZ-567804-A (NZ)
Title: Hydrogen G-cycle rotary internal combustion engine
Inventor: GUTHRIE BARRY R
IPC: F04C29/02
Filed: 2006-09-29
Abstract: Disclosed is a hydrogen G-cycle rotary vane internal combustion engine comprising: a stator including an inner surface defining a distorted oval-shaped cavity including at least a compression zone and an expansion zone; a rotor rotatable within the cavity, and including an outer surface, and a plurality of combustion cavities and a plurality of slots located along a periphery of the rotor; and a plurality of radially movable vanes disposed within the slots and extending to and slidably engaging the inner surface of the stator, so as to form a plurality of rotatable chambers within which a mixture of fuel is compressed for ignition in the plurality of rotor combustion cavities; and a vapor chamber overlying a portion the oval-shaped cavity and including a fluid for absorbing heat from the ignition of the fuel mixture in the rotor combustion cavities and returning heat to the combustion cavities as they rotate past the expansion zone.
Patent NZ-574274-A (NZ)
Title: Multithreat safety and security system and specification method thereof
Inventor: GARNIER BERNARD
IPC: G06F19/00
Filed: 2009-01-20
Abstract: A safety and security system for a definite area comprises sensors fit for capturing a first set of instant-track data on a first set of objects located in the area or in the vicinity thereof, information sources fit for capturing a second set of non instant-track data on a second set of objects and a set of computer processes fit for correlating members of the first set of objects with members of the second set of objects and for computing threat levels of the members of the first set of objects from the first and second sets of data assigned to the correlated members. The first set of instant-track data comprises at least real-time vector position and speed data from at least one sensor on at least one of the objects of the first set of objects. The second set of non-instant track data comprises at least an information piece on one of identification, position/behaviour history of at least one of the objects of the second set of objects. A method for designing the specification of a safety and security system for an area comprises at least one step of using a concept of operations document template and corresponding computer based modelling structure, and at least one step of defining through at least one interaction with some of the users of the system the missions to be performed by the system and the resources fit to accomplish the missions. The resources are of a type selected from a group comprising at least sensors fit for acquiring real-time vector position and speed data of the objects; information sources fit for acquiring at least an information piece on one of identification, position/behaviour history of at least one object, operations centres fit for performing computer processes for correlating members of a first set of objects with members of a second set of objects and for computing threat levels of the correlated members of the two sets of objects, communications network and manning requirements.
Patent NZ-576570-A (NZ)
Title: 7-sulfonylamino-2-thiazol and 2-thiadiazol -indole compounds
Inventor: YASUMA TSUNEO
IPC: A61K31/427
Filed: 2007-10-18
Abstract: Disclosed are indole compounds of formula (I) or a salt thereof, wherein the substituents are as defined in the specification, a glucokinase activator and a pharmaceutical agent comprising the compound and their use in treating diabetes and obesity.
Patent NZ-579614-A (NZ)
Title: Monoclonal antibodies for treatment of cancer
Inventor: SAHIN UGUR
IPC: C07K16/30
Filed: 2008-03-14
Abstract: Disclosed are antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing GT468, including tumor-related diseases such as breast cancer, lung cancer, gastric cancer, ovarian cancer, and hepatocellular cancer.
Patent NZ-583488-A (NZ)
Title: Determining module for transcoding transmissions based on codec indicator
Inventor: KAMPMANN DIRK
IPC: H04W76/02
Filed: 2008-09-04
Abstract: Disclosed is a method for use in a base station controller (30) of a mobile communication network for deciding on the placement of transcoding functionality for a call involving a user equipment (10). The base station controller (30) and a media gateway (45) are controlled by a mobile switching centre server (40). The mobile communication network communicates according to an IP Protocol. The method includes receiving, from the mobile switching centre server (40), an indication of a codec type applicable to the call. The method also includes receiving an indication of whether the transcoding of the codec type could be placed in the selected media gateway (45) and in a transcoder and rate adapter unit (35) assigned to the base station controller (30) for the call. The method further includes selecting to place the transcoding functionality either within the assigned transcoder and rate adapter unit (35) or within the selected media gateway (45) based on the received indication. Information on the selected codec and placement of the transcoding functionality is then sent to the mobile switching centre server (40). A base station controller (30) and a mobile switching centre server (40) for the performance of this method are also disclosed.
Patent NZ-587709-A (NZ)
Title: N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
Inventor: HUTCHINSON JOHN HOWARD
IPC: A61P11/00
Filed: 2009-01-29
Abstract: Disclosed is a N, N-disubstituted aminoalkylbiphenyl compound of formula (I) where the substituents are as disclosed in the description. Example of compounds of formula (I) are { 2'-((Acetyl-methyl-amino)-methyl)-6-methoxy-4'-trifluoromethyl-biphenyl-3-yl} -acetic acid; { 2'-((Acetyl-ethyl-amino)-methyl)-6-methoxy-4'-trifluoromethyl-biphenyl-3-yl} -acetic acid; (2'-{ (Acetyl-(2,2-dimethyl-propyl)-amino)-methyl} -6-methoxy-4'-trifluoromethyl-biphenyl-3-yl)-acetic acid. Also disclosed is the use of a compound of formula (I) for the manufacture of a medicament for the treatment of a PGD2-dependant or PGD2-mediated disease and a pharmaceutical composition containing a compound of formula (I). Examples of diseases include respiratory disease or condition, an allergic disease or condition, or an inflammatory disease such as asthma, rhinitis, allergic conjunctivitis, atopic dermatitis, chronic obstructive pulmonary disease.
Patent NZ-591525-A (NZ)
Title: Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
Inventor: PARR THOMAS R
IPC: A61K38/14
Filed: 2009-08-29
Abstract: 591525 Disclosed is the use of oritavancin, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent for the manufacture of a medicament for the complete and effective treatment of complicated skin and skin structure infection (cSSSI) in a subject, wherein the medicament is formulated to comprise at least about 900 mg of oritavancin, or a pharmaceutically acceptable salt thereof, and be administered to the subject in one dose over the course of therapy to thereby treat the bacterial infection.
Patent NZ-592576-A (NZ)
Title: A fixing system for cladding and a cladded structure
Inventor: CARBINES RICHARD JAMES
IPC: E04B2/02
Filed: 2011-04-29
Abstract: 592576 Disclosed is a cladded building structure with a support structure to allow more efficient and faster attachment of cladding panels or weatherboards. The support structure for cladding comprises rows of spaced-apart fixing devices mounted to the support structure such that the fixing devices are spaced apart vertically and horizontally relative to one another. Each fixing device comprises an engagement member for engaging with and supporting a cladding board, the engagement member comprising a seat surface that is angled upwardly relative to the horizontal. Rows of partially overlapping cladding boards cover the support structure, with each row of cladding boards being supported by a respective row of fixing devices. Each cladding board being defined along the length of the board by front and rear surfaces that extend between upper and lower surfaces of the cladding board, wherein adjacent rows of cladding boards overlap such that the front surface of a top portion of each cladding board substantially abuts a rear surface of a lower portion of a cladding board from an upper adjacent row of cladding boards. A recess being provided in and along the rear surface of each cladding board into which the engagement members of a number of fixing devices of a row engage to support the cladding board on the support structure such that each row of cladding boards is supported by a respective row of fixing devices and each recess of the cladding boards comprises a complementary angled engagement surface that is configured to sit upon the angled seat surfaces of the of the engagement members of its respective row of fixing devices in a hook-like engagement relationship to support the cladding boards in place on the support structure. Retaining gaps are formed between sections of the upper surface of each cladding board and lower surfaces of the row of fixing devices supporting the next upper adjacent cladding board; and a plurality of resiliently deformable retaining components being located in a deformed state in at least one retaining gap associated with each cladding board such that the retaining components act to exert a downward force on the upper surface of their respective cladding boards to retain them in an engaged state with their respective rows of fixing devices.
Patent NZ-594943-A (NZ)
Title: Hydraulic propellor enhancement method by admitting air or gas through pipes using bernoulli principle and compressing in contracting nozzle exit
Inventor: LIN ZUEI-LING
IPC: B63H11/08
Filed: 2011-08-31
Abstract: The present disclosure relates to a hydraulic propeller enhancement method for enhancing the propelling force of a hydraulic propeller 30, and uses a gas release outlet 40 in the propeller 32 at the area where the high-speed axial flow of water F passes for guiding in a gas by means of a negative pressure subject to Bemoulli's principle. Thus, subject to the principle, gas compressible characteristic and Boyle's law and the arrangement of the contracted end piece 341 of the nozzle 34 to work as an air compressor for compressing air bubbles 60, the invention uses one single gas guide device 50 and a negative pressure suction force to guide in air bubbles 60 to enhance the propelling force of the hydraulic propeller 30.